Tepnel Pharma Services

Executive Summary

Tepnel Pharma Services is a UK-based contract research organization (CRO) specializing in regulatory-compliant pharmaceutical testing for drug development. With expertise across small and large molecule APIs, investigational medicinal products, and finished dosage forms including inhalation, oral, parenteral, and biologics, the company plays a critical role in ensuring the safety and efficacy of new therapies. Founded in 1999 and headquartered in Manchester, Tepnel serves a global client base, providing high-quality laboratory data that supports clinical trial success and regulatory submissions. As a private entity, it has steadily built a reputation for technical excellence and compliance, positioning itself as a trusted partner in the outsourced pharmaceutical testing market, which continues to grow driven by increasing R&D spending and regulatory demands.

Upcoming Catalysts (preview)

• Q3 2026Expansion of Inhalation Testing Capabilities70% success
• Q4 2026Strategic Partnership with a Top-10 Pharma Company50% success
• Q2 2026Accreditation for New Biologics Testing Services85% success